Italia markets closed

BMY Jan 2025 65.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,1700-0,0100 (-5,56%)
Alla chiusura: 03:47PM EDT
Schermo intero
Chiusura precedente0,1800
Aperto0,2100
Denaro0,1500
Lettera0,2000
Prezzo d'esercizio65,00
Scadenza2025-01-17
Min-Max giorno0,1700 - 0,2100
Contratto - Min-MaxN/D
Volume11
Open Interest9,37k
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri